Leukemic B cells with an activation phenotype (CD69Pos) in patients with CLL display apoptosis resistance at a pre-mitochondrial level as a result of defective activation of Bax/Bak proteins. This evidence concerns the gene BAX and B-cell chronic lymphocytic leukemia.